Evidence map›Paper›PMID 39866267›Full record

ArticleAME case reports2025

Theophylline use-a conundrum in modern medicine: a case report.

Sai S Kommineni, Dedeepya Gullapalli, Tara Rahmlow, Shyam Subramanya Ganti, Jayaramakrishna Depa

Abstract readCase Reports
In one paragraph

Article in AME case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sai S KommineniDepartment of Internal Medicine, Appalachian Regional Healthcare, Harlan, KY, USA.ORCID https://orcid.org/0000-0002-2614-8172
Dedeepya GullapalliDepartment of Internal Medicine, Appalachian Regional Healthcare, Harlan, KY, USA.ORCID https://orcid.org/0000-0002-9101-3450
Tara RahmlowDepartment of Internal Medicine, Appalachian Regional Healthcare, Harlan, KY, USA.
Shyam Subramanya GantiDepartment of Pulmonary and Critical Care, Appalachian Regional Healthcare, Harlan, KY, USA.ORCID https://orcid.org/0000-0002-2042-0964
Jayaramakrishna DepaDepartment of Nephrology, Appalachian Regional Healthcare, Harlan, KY, USA.ORCID https://orcid.org/0000-0002-2381-6155

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The theophylline toxidrome presents with multisystemic involvement that includes cardiovascular, neurologic, metabolic, musculoskeletal, and gastrointestinal manifestations. Considering such a varied spectrum of presentations, it is often difficult to ascertain the diagnosis of this particular toxidrome. Review of home medications is an important step when working with a patient presenting as a toxidrome. Case Description: The case report is about a 69-year-old female patient who was brought to the emergency room in status epilepticus and atrial fibrillation with rapid ventricular response. She had a prolonged state of drowsiness following an initial antiepileptic therapy and a toxicologic screen positive for toxic levels of theophylline at 59.7 mcg/mL. Emergent dialysis was performed leading to improvement of her overall clinical status. We suspect the patient had built up toxic levels of theophylline due to evolving drug interactions after she discontinued many of her routine home medications following her husband's death. Conclusions: Theophylline is a methylxanthine derivative medication that is used sparingly in the treatment of airway diseases. It has become less favorable over the years due to its narrow therapeutic index and potential for development of toxicity. Monitoring serum drug levels and adjusting the dose frequently to maintain a therapeutic range is essential to prevent toxicity related to theophylline. There is emerging evidence that the drug might have anti-inflammatory properties to aid in treating many chronic airway disorders and pharmacovigilance is necessary for its continued use.

Indexed as

airway diseasescase reportTheophyllinetoxicity

Identifiers

PMID39866267
PMCPMC11760928

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.